GCSHP3: A Drug Target / Disease Biomarker (G100329109)

Target Name: GCSHP3

NCBI ID: G100329109

GCSHP3

Other Name(s): GCSH pseudogene 3

GCSHP3: A Drug Target / Disease Biomarker

GCSHP-3, also known as GCSHP-3A, is a drug target and a potential biomarker for various diseases, including cancer. GCSHP-3 is a transmembrane protein that is expressed in various tissues and cells in the body. Its function in the body is not yet fully understood, but research has shown that it plays a significant role in several cellular processes, including cell signaling, angiogenesis, and inflammation.

One of the key features of GCSHP-3 is its ability to interact with various signaling pathways. GCSHP-3 has been shown to be involved in several signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway. These signaling pathways are involved in various cellular processes that are important for the development and progression of diseases, including cancer.

GCSHP-3 has also been shown to play a role in the regulation of cellular processes that are important for maintaining tissue homeostasis. For example, studies have shown that GCSHP-3 is involved in the regulation of cell adhesion, migration, and invasion, as well as in the regulation of angiogenesis.

In addition to its role in cellular signaling, GCSHP-3 has also been shown to play a role in the regulation of inflammation. Studies have shown that GCSHP-3 is involved in the regulation of immune cell function, including the regulation of T cell responses and the regulation of inflammation.

GCSHP-3 has also been shown to be involved in the regulation of cellular processes that are important for the development and progression of diseases, including cancer. For example, studies have shown that GCSHP-3 is involved in the regulation of the angiogenic process, which is the process by which new blood vessels form in the body. This is important for the development of cancer, as the growth and progression of cancer often involves the formation of new blood vessels.

GCSHP-3 has also been shown to play a role in the regulation of cellular processes that are important for maintaining tissue repair and regeneration. Studies have shown that GCSHP-3 is involved in the regulation of cell proliferation, apoptosis, and regeneration, which are processes that are important for the repair and regeneration of damaged tissue in the body.

GCSHP-3 has also been shown to play a role in the regulation of cellular processes that are important for the development and progression of diseases, including neurodegenerative diseases. For example, studies have shown that GCSHP-3 is involved in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

GCSHP-3 has also been shown to play a role in the regulation of cellular processes that are important for the development and progression of diseases, including cardiovascular diseases. Studies have shown that GCSHP-3 is involved in the regulation of cardiovascular diseases, including heart failure and hypertension.

GCSHP-3 has also been shown to play a role in the regulation of cellular processes that are important for the development and progression of diseases, including diseases of the immune system. For example, studies have shown that GCSHP-3 is involved in the regulation of immune cell function, including the regulation of T cell responses and the regulation of inflammation.

In conclusion, GCSHP-3 is a drug target and a potential biomarker for various diseases. Its role in cellular signaling, angiogenesis, inflammation, tissue homeostasis, and disease development and progression is still fully understood. Further research is needed to fully understand the function of GCSHP-3 and its potential as a drug target and biomarker.

Protein Name: GCSH Pseudogene 3

The "GCSHP3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GCSHP3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets